The University of Wisconsin-Madison?s patent licensing arm on Wednesday responded to critics who claim a stem cell patent it holds should be invalidated in light of the U.S. Supreme Court?s recent Myriad Genetics Inc. decision, telling the Federal Circuit the patent was the result of a biologist?s pioneering research. (Subscription required.)
Office of Strategic Communication